SUPPLEMENTAL INFORMATION - Impact of Systemic Therapies in Metastatic Melanoma of Unknown Primary: A study from MELBASE, a French Multicentric Prospective Cohort
Published: 2 September 2022| Version 1 | DOI: 10.17632/6vndghdrtg.1
Contributors:
Perrine ROUSSET,
Henri Montaudié
Description
Supplemental material for Manuscript: Impact of Systemic Therapies in Metastatic Melanoma of Unknown Primary: A study from MELBASE, a French Multicentric Prospective Cohort
Files
Categories
Supplementation